Featured by Newsweek & World Class Media Outlets

Interviews

Industry

Kyoko (Kay) Deguchi
Kyoko (Kay) Deguchi
CEO
PHC Group
2024-04-12

The ability to translate our vast technological and human resources into tangible healthcare solutions is crucial.

READ MORE
Glenn Hunzinger
Glenn Hunzinger
US Pharma and Life Sciences Leader
PwC
2024-04-12

In the future, the life sciences industry is likely to be significantly influenced by the increasing consumerism in healthcare.

READ MORE
Sebastian Guth
Sebastian Guth
Chief Operating Officer for Bayer Pharmaceuticals and President at Bayer US
Bayer
2024-04-12

For Bayer, technology is not just about innovation for its own sake but about how it can be leveraged to make a real impact on patient care.

READ MORE
Fabian Gerlinghaus
Fabian Gerlinghaus
CEO & Co-Founder
Cellares
2024-04-11

About 20% of patients are dying on the waitlist even though they are eligible for approved cell therapies because the industry is unable to meet patient demand. This is largely due to the lack of automated, high-throughput cell therapy manufacturing technologies.

READ MORE
Dr. Abdulkader Rahmo
Dr. Abdulkader Rahmo
President and CSO
SMSbiotech
2024-04-11

SMS cells possess distinct characteristics in terms of stability, size, shape, and specific binding abilities to crucial cells in the body, such as progenitor stem cells and mesenchymal stem cells. 

READ MORE
Peter Maag
Peter Maag
CEO
Kyverna Therapeutics
2024-04-11

Our focus has been on developing a pipeline that includes rheumatology and neurology, we are also optimistic about applying these T cells to lupus nephritis and multiple sclerosis (MS). At a high level, autoimmune diseases involve the immune system attacking itself. We extract T cells from the patient, genetically re-engineer them, and re-inject them. It reminds me of resetting a computer to get everything back to normal. 

READ MORE
Robert Langer
Robert Langer
Institute Professor
MIT
2024-04-10

Yet, what is truly thrilling is the potential for discoveries that are currently beyond our imagination. Just as CRISPR emerged from basic research to revolutionize genetics, future breakthroughs will likely come from areas we are not even focused on today. It underscores the importance of supporting fundamental, curiosity-driven research—it is the wellspring from which the next big innovations will emerge.

 

READ MORE
Mark Vineis
Mark Vineis
Country President
Novartis Canada
2024-04-10

There's a noticeable tension between the nurturing of biotech innovation and the bureaucratic barriers to healthcare innovation.

READ MORE
Carl Hansen
Carl Hansen
Ph.D, founder and CEO
AbCellera
2024-04-05

AbCellera, continuing its trajectory in the antibody therapeutics space, has been building a comprehensive "engine" since 2012, encompassing people, technology, infrastructure, and intellectual property.

READ MORE
Wendy Hurlburt
Wendy Hurlburt
President & CEO
Life Sciences British Columbia
2024-04-05

British Columbia stands out in the life sciences due to its historic investment in research, fostering innovations in therapeutic and innovative areas.

READ MORE